TrangAston :verified: on Nostr: #Cardioimmunology #Cardiomastodon @NatureMedicine In the setting of combined ...
#Cardioimmunology #Cardiomastodon @NatureMedicine In the setting of combined high-potency statin therapy, niacin (B3) not only failed to diminish CVD risk , but in a meta-analysis of the most recent trials, it even heightened overall mortality . It has thus been recognized that niacin has a more complex effect on CVD events (the so-called ‘niacin paradox’, wherein it lowers LDL cholesterol but not #CVD event risk), presumably through mechanism(s) independent of cholesterol.
Published at
2024-02-20 05:48:25Event JSON
{
"id": "232147094468ce9181fca5a68cc18d2aa6aaa7c9a97833d0d028d79f9307efc5",
"pubkey": "f264865f87f2ba53c9849e8fbfdce8fa2d3b4d8e80c6c5af590a61b35009ca9a",
"created_at": 1708408105,
"kind": 1,
"tags": [
[
"t",
"cardioimmunology"
],
[
"t",
"cardiomastodon"
],
[
"t",
"cvd"
],
[
"proxy",
"https://med-mastodon.com/users/CastlTrAstonDrs/statuses/111962233606327992",
"activitypub"
]
],
"content": "#Cardioimmunology #Cardiomastodon @NatureMedicine In the setting of combined high-potency statin therapy, niacin (B3) not only failed to diminish CVD risk , but in a meta-analysis of the most recent trials, it even heightened overall mortality . It has thus been recognized that niacin has a more complex effect on CVD events (the so-called ‘niacin paradox’, wherein it lowers LDL cholesterol but not #CVD event risk), presumably through mechanism(s) independent of cholesterol.\n\nhttps://cdn.masto.host/medmastodoncom/media_attachments/files/111/962/215/803/117/366/original/24a55295ac045899.jpeg",
"sig": "2888859d037ccfedec09edeef087f5899dd0f54d3fb3da70ccbbef0f5b270109bfb7d0d23bbb933e84506b80f39066e3d0638192ec7731daf3bbeec5a01ee93e"
}
